NASDAQ:IMAC - IMAC Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.02 +0.12 (+3.08 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$4.02
Today's Range$3.84 - $4.2475
52-Week Range$2.60 - $4.60
Volume13,161 shs
Average Volume38,542 shs
Market Capitalization$29.10 million
P/E RatioN/A
Dividend YieldN/A
IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:IMAC



Sales & Book Value

Annual SalesN/A



Market Cap$29.10 million
Next Earnings DateN/A
OptionableNot Optionable

IMAC (NASDAQ:IMAC) Frequently Asked Questions

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

Has IMAC been receiving favorable news coverage?

Media stories about IMAC stock have trended negative this week, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. IMAC earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of IMAC's key competitors?

Who are IMAC's key executives?

IMAC's management team includes the folowing people:
  • Mr. Jeffrey S. Ervin M.B.A., CEO & Director (Age 41)
  • Mr. D. Anthony Bond CPA, Chief Financial Officer (Age 56)
  • Dr. Matthew C. Wallis, COO & Director (Age 44)
  • Mr. Jeff Ervin, Chief Exec. Officer
  • Mr. Ian A. White Ph.D., Chief Scientific Officer (Age 45)

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

When does the company's quiet period expire?

IMAC's quiet period expires on Monday, March 25th. IMAC had issued 850,000 shares in its IPO on February 13th. The total size of the offering was $4,360,500 based on an initial share price of $5.13. During the company's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $4.02.

How big of a company is IMAC?

IMAC has a market capitalization of $29.10 million.

What is IMAC's official website?

The official website for IMAC is

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]

MarketBeat Community Rating for IMAC (NASDAQ IMAC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote "Outperform" if you believe IMAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by Staff

Featured Article: 12b-1 Fees

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel